Literature DB >> 19718777

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.

R G Kay1, C Barton, C P Velloso, P R Brown, C Bartlett, A J Blazevich, R J Godfrey, G Goldspink, R Rees, G R Ball, D A Cowan, S D Harridge, J Roberts, P Teale, C S Creaser.   

Abstract

Insulin-like growth factor-I (IGF-I) is a known biomarker of recombinant human growth hormone (rhGH) abuse, and is also used clinically to confirm acromegaly. The protein leucine-rich alpha-2-glycoprotein (LRG) was recently identified as a putative biomarker of rhGH administration. The combination of an ACN depletion method and a 5-min ultra-high-performance liquid chromatography/tandem mass spectrometry (uHPLC/MS/MS)-based selected reaction monitoring (SRM) assay detected both IGF-I and LRG at endogenous concentrations. Four eight-point standard addition curves of IGF-I (16-2000 ng/mL) demonstrated good linearity (r(2) = 0.9991 and coefficients of variance (CVs) <13%). Serum samples from two rhGH administrations were extracted and their uHPLC/MS/MS-derived IGF-I concentrations correlated well against immunochemistry-derived values. Combining IGF-I and LRG data improved the separation of treated and placebo states compared with IGF-I alone, further strengthening the hypothesis that LRG is a biomarker of rhGH administration. Artificial neural networks (ANNs) analysis of the LRG and IGF-I data demonstrated an improved model over that developed using IGF-I alone, with a predictive accuracy of 97%, specificity of 96% and sensitivity of 100%. Receiver operator characteristic (ROC) analysis gave an AUC value of 0.98. This study demonstrates the first large scale and high throughput uHPLC/MS/MS-based quantitation of a medium abundance protein (IGF-I) in human serum. Furthermore, the data we have presented for the quantitative analysis of IGF-I suggest that, in this case, monitoring a single SRM transition to a trypsin peptide surrogate is a valid approach to protein quantitation by LC/MS/MS. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718777     DOI: 10.1002/rcm.4237

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  10 in total

1.  Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing.

Authors:  Hongyan Li; Robert Ortiz; Linh T B Tran; Hossein Salimi-Moosavi; Jennifer Malella; Christopher A James; Jean W Lee
Journal:  AAPS J       Date:  2012-12-12       Impact factor: 4.009

2.  Differentiation of Common IGF-1 Variants Using HRMS COM Determination with Follow-Up MS/MS Verification.

Authors:  Nicholas E Larkey; Erica M Fatica; Ravinder J Singh
Journal:  Methods Mol Biol       Date:  2022

3.  Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.

Authors:  Paul E Oran; Olgica Trenchevska; Dobrin Nedelkov; Chad R Borges; Matthew R Schaab; Douglas S Rehder; Jason W Jarvis; Nisha D Sherma; Luhui Shen; Bryan Krastins; Dawn C Schwenke; Peter D Reaven; Randall W Nelson
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

4.  Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry.

Authors:  Mårten Sundberg; Emma M Strage; Jonas Bergquist; Bodil S Holst; Margareta Ramström
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

5.  Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.

Authors:  Richard Kin Ting Kam; Chung Shun Ho; Michael Ho Ming Chan
Journal:  EJIFCC       Date:  2016-12-01

6.  Production-related contaminants (pesticides, antibiotics and hormones) in organic and conventionally produced milk samples sold in the USA.

Authors:  Jean A Welsh; Hayley Braun; Nicole Brown; Caroline Um; Karen Ehret; Janet Figueroa; Dana Boyd Barr
Journal:  Public Health Nutr       Date:  2019-06-26       Impact factor: 4.022

7.  An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma.

Authors:  Mark S Pratt; Martijn van Faassen; Noah Remmelts; Rainer Bischoff; Ido P Kema
Journal:  Anal Bioanal Chem       Date:  2021-02-10       Impact factor: 4.142

Review 8.  Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.

Authors:  David A Cowan; Danielle A Moncrieffe
Journal:  Drug Test Anal       Date:  2021-09-06       Impact factor: 3.234

9.  Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome.

Authors:  Pavel Májek; Zuzana Reicheltová; Jiří Suttnar; Jaroslav Cermák; Jan E Dyr
Journal:  Proteome Sci       Date:  2012-05-08       Impact factor: 2.480

10.  Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.

Authors:  Eric E Niederkofler; David A Phillips; Bryan Krastins; Vathany Kulasingam; Urban A Kiernan; Kemmons A Tubbs; Scott M Peterman; Amol Prakash; Eleftherios P Diamandis; Mary F Lopez; Dobrin Nedelkov
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.